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Abstract
Background: As malaria control efforts intensify, it is critical to monitor trends in disease burden
and measure the impact of interventions. A key surveillance indicator is the incidence of malaria.
Yet measurement of incidence is challenging. The slide positivity rate (SPR) has been used as a
surrogate measure of malaria incidence, but limited data exist on the relationship between SPR and
the incidence of malaria.
Methods: A cohort of 690 children aged 1-10 years at enrollment were followed for all their
health care needs over a four-year period in Kampala, Uganda. All children with fever underwent
laboratory testing, allowing us to measure the incidence of malaria and non-malaria fevers. A
formula was derived to estimate relative changes in the incidence of malaria (rΔIm) based on
changes in the SPR and the assumption that the incidence of non-malaria fevers was consistent over
time. Observed and estimated values of rΔIm were compared over two, six, and 12 month time
intervals after restricting the analysis to children contributing observation time between the ages
of 4-10 years to control for aging of the cohort.
Results: Over the four-year observation period the incidence of malaria declined significantly from
0.93 episodes per person-year in 2005 to 0.39 episodes per person-year in 2008 (p < 0.0001) and
the incidence of non-malaria fevers declined significantly from 2.31 episodes per person-year in
2005 to 1.31 episodes per person-year in 2008 (p < 0.0001). Younger age was associated with a
significantly greater incidence of malaria and the incidence of malaria was significantly higher during
seasonal peaks occurring each January-February and May-June. Changes in SPR produced
reasonably accurate estimates of rΔIm over all time intervals. The average absolute difference in
observed and estimated values of rΔIm was lower for six-month intervals (0.13) than it was for
two-month (0.21) or 12 month intervals (0.21).
Conclusion: Changes in SPR provided a useful estimate of changes in the incidence of malaria in
a well defined cohort; however, a gradual decline in the incidence of non-malaria fevers introduced
some bias in these estimates.
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Background
Malaria remains one of the most important global health
challenges, with an estimated three billion people at risk
of infection, leading to approximately 250 million cases
and one million deaths each year [1]. Efforts to reduce the
burden of malaria have intensified recently through the
use of effective tools for malaria control, notably long-
lasting insecticide-treated nets (LLITN) and artemisinin-
based combination therapy (ACT), backed by indoor
residual spraying (IRS) of insecticides. These efforts have
been made possible by improved policy recommenda-
tions and increased support from governments, interna-
tional organizations, and donors. These expanding
resources have come with ambitious targets for control
and expectations of significant reductions in disease bur-
den. As an example, in 2005 the World Health Assembly
set a target of reducing malaria cases and deaths per capita
by 50% between 2000 and 2010, and by 75% between
2005 and 2015 [2].
As malaria control efforts intensify, it is critical to monitor
disease burden and trends, and to measure the impact of
interventions [3]. The incidence of malaria, defined as the
number of confirmed malaria cases per person-time, is
one of the key indicators for monitoring and evaluation
[1]. The general working definition of a case of malaria is
considered to be "fever with malarial parasitaemia",
which normally defines all patients that require anti-
malarial treatment [1]. The most accurate method of esti-
mating malaria incidence involves longitudinal studies in
defined populations, where all cases of suspected malaria
(i.e. those with fever) are captured and undergo a diagnos-
tic test that is highly sensitive and specific. However, such
methods require considerable resources and are rarely
undertaken as part of routine malaria surveillance pro-
grammes. Malaria incidence is typically estimated based
on the number of reported cases of malaria captured
through a country's health management information sys-
tem (HMIS). However, there is often a significant lag time
before HMIS data become available. In addition, incom-
plete reporting, lack of a clear denominator, and the
absence of laboratory confirmation limit the accuracy of
these data [4], particularly in African countries where the
vast majority of reported cases of malaria are not labora-
tory confirmed [3]. Although statistical adjustments can
improve the accuracy of estimates of malaria incidence
based on HMIS data, temporal variations in reporting,
varied utilization of health care services, and limitations
on the accuracy of diagnostic testing can lead to consider-
able bias and confound attempts to define the relation-
ship between malaria incidence and control
interventions.
The slide positivity rate (SPR), defined as the number of
laboratory-confirmed malaria cases per 100 suspected
cases examined, provides an alternative method for esti-
mating temporal changes in malaria incidence. Compared
to clinical definitions of malaria, the SPR gains accuracy in
considering only laboratory confirmed cases of malaria,
and it can provide a rapid and inexpensive means of
assessing the burden of malaria in a population utilizing
health care facilities. The SPR has been used in cross-sec-
tional studies to define the level of malaria endemicity
[5,6]. Decreases in the SPR have been cited as evidence for
successful malaria control interventions in Africa [7,8], yet
there has been little work describing the quantitative rela-
tionship between temporal changes in SPR and changes in
malaria incidence using empiric data.
To better characterize the quantitative relationship
between SPR and the incidence of malaria we compared
changes in these metrics over a 4 year period within a
cohort of children in Kampala. This cohort was character-
ized by a highly incentivized study protocol designed to
maximize the capture of all illnesses, uniform diagnostic
testing for all episodes of fever, and a highly accurate diag-
nostic testing system. This study allowed us to directly
compare observed changes in the incidence of malaria
with changes in incidence of malaria estimated from the
SPR.
Methods
Study site and recruitment of study participants
Subjects were recruited from the Mulago III parish of
Kampala, Uganda, a densely populated urban slum
approximately 1 square kilometer in area. Malaria in
Kampala is meso-endemic, with two peaks in incidence
following the rainy seasons of December-January and
April-May [9]. Prior to the start of the study, a census sur-
vey was conducted within the parish to provide a sam-
pling frame for study recruitment, as previously described
[10]. Between November 2004 and April 2005, 601 chil-
dren from households randomly selected from our census
survey were enrolled in a prospective cohort study if they
fulfilled all of the following eligibility criteria: 1) age 1 to
10 years; 2) agreement to come to the study clinic for any
febrile episode or illness; 3) agreement to avoid medica-
tions administered outside the study; 4) agreement to
remain in Kampala during the study period; 5) no known
side effects to the study medications; 6) weight > 10 kg; 7)
absence of severe malnutrition or known serious chronic
disease; 8) absence of life threatening screening labora-
tory results; and 9) willingness of parent or guardian to
provide written informed consent. An additional 89 chil-
dren were enrolled February - May 2007 using the same
eligibility criteria. These children were living in the same
households as previously enrolled children but either too
young or not yet born at the time of the initial recruitment
period.Malaria Journal 2009, 8:213 http://www.malariajournal.com/content/8/1/213
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Follow-up of study participants
Details of the study follow-up have been previously
described [11] and are summarized here. Participants
were asked to come to a designated study clinic, open 7
days a week, for all healthcare needs. Subjects who pre-
sented to the clinic with fever (tympanic temperature ≥
38.0°C) or reported history of fever symptoms in the pre-
vious 24 hours had blood obtained by fingerprick for a
thick blood smear. If the thick blood smear was positive,
the participant was diagnosed with and treated for malaria
regardless of the parasite density. The first time a subject
was diagnosed with uncomplicated malaria, he/she was
randomized to receive one of the following anti-malarial
combination therapies: amodiaquine + sulphadoxine-
pyrimethamine (AQ + SP), amodiaquine + artesunate
(AQ + AS), or artemether-lumefantrine (AL). For any sub-
sequent episode of uncomplicated malaria during the
remainder of the study, subjects received the same therapy
to which they were randomized. Subjects who had recur-
rence of symptomatic malaria within 14 days were given
quinine. Participants with severe malaria or danger signs
were also treated with quinine. If, upon any presentation,
the thick blood smear was negative, the participant was
not given anti-malarial therapy and was managed at the
discretion of the study physicians. The diagnosis and
management of malaria was based on initial readings of
blood smears. Final microscopy results were based on a
rigorous quality control system which included re-reading
all blood smears by a second microscopist and resolution
of any discrepancies by a third microscopist. Of note, no
patients diagnosed with uncomplicated malaria based on
the initial smear reading were deemed to have a negative
smear following the quality control readings.
Data on ITN use was collected at enrollment, although no
intervention was made at that time. All participants were
given a LLITN between May and June of 2006. In March
2007, the AQ + SP treatment arm was dropped due to
poor efficacy. In January 2008 the AQ + AS treatment arm
was dropped because the AS component of this regimen
was no longer available in Uganda. Study participants
were prematurely withdrawn from the study if they met
any of the following criteria: 1) movement out of the
study area, 2) inability to locate study participants for > 60
consecutive days, 3) withdrawal of informed consent, and
4) inability to comply with the study schedule and proce-
dures. Observation for new episodes of malaria was termi-
nated on December 15th, 2008, and the study was
completed on January 31, 2009.
Statistical analysis
Data was double-entered in Access (Microsoft Corpora-
tion, Redmond, WA) and analyzed using STATA Version
10 (College Station, TX) and Microsoft Excel (Microsoft
Corp. Redmond, Wa). To control for changes in the age of
the cohort over time, data were only included for children
who were 4-10 years of age between January 2005 and
December 2008. The incidence of malaria (Im) was
defined as the number of treatments for malaria divided
by the person-time of observation in years. SPR was
defined as the number of treatments for malaria (all based
on a positive blood smear) divided by the total number of
blood smears done among study participants who pre-
sented with an episode of fever. The observed relative
change in the incidence of malaria (rΔIm) was defined as
Imi+1/Imi, where i represents the baseline time interval
and i+1 represents the interval immediately following. To
estimate rΔIm using SPR, the following assumptions were
made: 1) all fevers in the study population were captured,
2) all study participants who presented with fever under-
went microscopy, and 3) the sensitivity and specificity of
microscopy was 100%. Given these assumptions, during
any time period SPR can be defined by the following
equation:
where Inm represents the incidence of fever not due to
malaria. If Inm does not change from one time interval to
the next, rΔIm can be estimated from the SPR by the fol-
lowing formula:
where i represents the baseline time interval and i+1 rep-
resents the interval immediately following. The observed
and estimated rΔIm were compared across two month, six
month, and 12 month time intervals. Relative changes in
incidence were always made in reference to consecutive
intervals of time such that over the 4 year observation
periods there were 23, 7, and 3 estimates of rΔIm across
two, six, and 12 month intervals, respectively. Agreement
between the observed and estimated values of rΔIm for
these intervals was assessed using three methods; direc-
tionality (relative increase or decrease in the incidence of
malaria), overestimation versus underestimation, and
average absolute difference in rΔIm.
Continuous variables were compared using the t-test for
two-group comparisons and ANOVA for comparisons of
three or more groups. Comparisons of the incidence of
malaria and non-malaria fever were made using a negative
binomial regression model with exposure reflected by the
observation time. A p-value < 0.05 was considered statis-
tically significant.
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Results
Description of cohort
The characteristics of the study cohort stratified by the
year of observation are summarized in Table 1. Of the 690
children enrolled in the cohort, 574 were observed
between the ages of 4-10 years contributing a total of
1,266 person-years of follow-up with a median follow-up
time per child of 2.01 years (IQR 1.03-3.33 years). The
mean age of the children followed in 2005 was signifi-
cantly lower than that of children observed during the
subsequent three years (6.80 vs. 7.16 years, p = 0.0006),
but mean age was not significantly different between the
final three years of follow-up (p = 0.82). The proportion
of observation days with ITN coverage was low (5.4%)
during the first year of the study but increased to almost
100% in May of 2006 when all of the study participants
were given LLITNs. Changes in the proportion of different
anti-malarial treatment regimens given reflected changes
in treatment efficacy and the study protocol. AQ + SP
made up of the largest proportion of treatments in 2005-
06 due to its lower efficacy (and, therefore, increased need
for retreatment of failures) [11] and this regimen was
dropped in 2007. The AQ + AS treatment arm was
dropped in early 2008, making AL the predominant treat-
ment used in the final year of observation. The use of qui-
nine for complicated malaria and treatment failures made
up only a small proportion (2.5%) of the total treatments.
Incidence of malaria and non-malaria fever
Over the four-year observation period there were a total of
925 episodes of malaria and 2,233 episodes of non-
malaria fever, resulting in an incidence of malaria of 0.73
per person-year, and an incidence of non-malaria fever of
1.76 per person-year. Observed data for the incidence of
malaria and non-malaria fever over two-month time
intervals are presented in Table 2. Both the incidence of
malaria and the incidence of non-malaria fever were sig-
nificantly associated with age and time of year (Table 3).
Children 4-5 years of age had a similar incidence of
malaria compared to those 6-7 years of age (0.91 vs. 0.72
episodes per person-year, p = 0.22), but a significantly
higher incidence of malaria compared to those 8-10 years
of age (0.91 vs. 0.58 episodes per person-year, p = 0.001).
Children 4-5 years of age had a significantly higher inci-
dence of non-malaria fever compared to older children
(2.18 vs. 1.58 episodes per person-year, p < 0.0001) but
the incidence of non-malaria fever was similar for those 6-
7 years of age compared to those 8-10 years of age (1.66
vs. 1.50 episodes per person-year, p = 0.13). The incidence
of malaria was significantly higher during the months of
January-February and May-June following the two rainy
seasons compared to the rest of the year (1.18 vs. 0.51 epi-
sodes per person-year, p < 0.0001). The incidence of non-
malaria fever had a single peak during the months May-
June that was significantly higher compared to the rest of
the year (2.52 vs. 1.61 episodes per person-year, p <
0.0001). Over the four-year observation period the inci-
dence of malaria declined significantly from 0.93 epi-
sodes per person-year in 2005 to 0.39 episodes per
person-year in 2008 (p < 0.0001) (Table 1). Over the four-
year observation period the incidence of non-malaria
fevers also declined significantly from 2.31 episodes per
person-year in 2005 to 1.31 episodes per person-year in
2008 (p < 0.0001) (Table 1). The majority of non-malaria
Table 1: Characteristics of cohort stratified by year of observation
Characteristics Year of observation
2005 2006 2007 2008
Number of children* 433 425 396 319
Person-years of follow-up 349 348 312 258
Mean age in years (SD) 6.80 (1.81) 7.11 (1.93) 7.19 (1.93) 7.19 (1.84)
ITN coverage† 5.4% 64.4% 99.8% 100%
Total blood smears performed 1133 937 650 438
Positive blood smears 326 302 196 101
Malaria treatment given‡
AQ + SP 123 123 24 0
AQ + AS 111 79 71 8
AL 83 94 94 92
Q u i n i n e 9671
Slide positivity rate (SPR) 28.8% 32.2% 30.2% 23.1%
Incidence of malaria£ 0.93 0.87 0.63 0.39
Incidence of non-malaria fever£ 2.31 1.83 1.46 1.31
*Number of children contributing at least one day of follow up to yearly analysis
†Proportion of observation days with ITN coverage
‡AQ = amodiaquine; SP = sulfadoxine-pyrimethamine; AS = artesunate; AL = artemether-lumefantrine
£per person-yearMalaria Journal 2009, 8:213 http://www.malariajournal.com/content/8/1/213
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Table 2: Smear positivity rate and incidence of malaria and non-malaria fever over time
Year Months Total BS* Positive BS* Person-years SPR Incidence of malaria† Incidence of non-malaria fevers†
2005 Jan-Feb 132 67 34.5 50.80% 1.94 1.88
Mar-Apr 179 51 55.7 28.50% 0.92 2.3
May-Jun 304 81 62.9 26.60% 1.29 3.54
Jul-Aug 208 50 65.5 24.00% 0.76 2.41
Sept-Oct 164 29 65.9 17.70% 0.44 2.05
Nov-Dec 146 48 64.7 32.90% 0.74 1.52
2006 Jan-Feb 154 63 58.8 40.90% 1.07 1.55
Mar-Apr 165 55 58 33.30% 0.95 1.9
May-Jun 260 95 57.2 36.50% 1.66 2.88
Jul-Aug 133 26 57.9 19.50% 0.45 1.85
Sept-Oct 104 19 57.9 18.30% 0.33 1.47
Nov-Dec 121 44 57.7 36.40% 0.76 1.33
2007 Jan-Feb 156 89 52.5 57.10% 1.7 1.28
Mar-Apr 100 25 53.2 25.00% 0.47 1.41
May-Jun 127 32 52.8 25.20% 0.61 1.8
Jul-Aug 101 13 53 12.90% 0.25 1.66
Sept-Oct 86 16 51.1 18.60% 0.31 1.37
Nov-Dec 80 21 49 26.30% 0.43 1.2
2008 Jan-Feb 74 27 46.4 36.50% 0.58 1.01
Mar-Apr 78 12 46.3 15.40% 0.26 1.43
May-Jun 100 32 45.5 32.00% 0.7 1.49
Jul-Aug 73 11 45.3 15.10% 0.24 1.37
Sept-Oct 62 8 43.4 12.90% 0.18 1.24
Nov-Dec 51 11 31 21.60% 0.35 1.29
*blood smear
†per person-year
Table 3: Associations between age and seasonality the incidence of malaria and non-malaria fever.
Incidence of malaria
Category Group Episodes Person years Incidence IRR* (95% CI) p-value
Age 4-5 years 358 394 0.91 1.0 (reference) -
6-7 years 303 418 0.72 0.85 (0.66-1.10) 0.22
8-10 years 264 454 0.58 0.64 (0.50-0.84) 0.001
Season Mar-Apr + Jul-Dec 439 856 0.51 1.0 (reference) -
Jan-Feb + May-Jun 486 411 1.18 2.52 < 0.001
Non-malaria fever
Age 4-5 years 857 394 2.18 1.0 (reference) -
6-7 years 693 418 1.66 0.75 (0.64-0.87) < 0.001
8-10 years 683 454 1.5 0.66 (0.57-0.77) < 0.001
Season Rest of the year 1682 1048 1.61 1.0 (reference) -
May-Jun 551 219 2.52 1.57 (1.40-1.77) < 0.001
*Incidence rate ratio estimated using a negative binomial regression modelMalaria Journal 2009, 8:213 http://www.malariajournal.com/content/8/1/213
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fever cases (80%) were due to one of four diagnoses; com-
mon cold, pharyngitis, upper respiratory tract infection,
and fever not otherwise specified.
Comparison of observed and estimated changes in the 
incidence of malaria
Relative changes in the incidence of malaria (rΔIm) using
observed data and that estimated from the SPR were com-
pared over two, six and 12 month intervals (Figure 1).
Using two-month time intervals the relative change in the
incidence of malaria ranged from 0.27-2.71 for the
observed values and 0.25-2.59 for the estimated values.
Using six-month time intervals the relative change in the
incidence of malaria ranged from 0.35-1.80 for the
observed values and 0.37-1.86 for the estimated values.
Using 12 month time intervals the relative change in the
incidence of malaria ranged from 0.62-0.93 for the
observed values and 0.69-1.18 for the estimated values.
The observed and estimated rΔIm had the same direction-
ality (relative increase or decrease in the incidence of
malaria) in 22 of 23 (96%) two-month intervals, seven of
seven (100%) six-month intervals, and two of three
(67%) 12 month intervals. The estimated rΔIm was higher
than the observed rΔIm in 13 of 23 (57%) two-month
intervals, six of seven (86%) six-month intervals, and
three of three (100%) 12 month intervals. The average
absolute difference in observed and estimated values of
rΔIm was lower for six-month intervals (0.13) than it was
for either two-month (0.21) or 12 month intervals (0.21).
Discussion
As efforts to reduce the burden of malaria increase, there
is a vital need to accurately measure the impact of control
interventions. The vast majority of malaria control inter-
ventions are not implemented as controlled experiments,
therefore it is important to develop standardized metrics
and methods for estimating their impact through routine
surveillance. One of the most important metrics for
malaria monitoring and evaluation is the incidence of dis-
ease (i.e. the number of cases of malaria per person-time).
Estimated vs. Observed Change in Malaria Incidence Figure 1
Estimated vs. Observed Change in Malaria Incidence. Estimated versus observed relative change in the incidence of 
malaria (incidence of malaria in the current time interval/incidence of malaria in the prior time interval) over two, six, and 12 
month intervals between January 2005 and December 2008. Y-axis expressed in terms of the incidence rate ratio (i.e. 2 equals 
a 2-fold increase in the incidence of malaria and 0.5 equals a 2-fold decrease in the incidence of malaria) and X-axis expressed 
in terms of calendar time.
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However, direct measures of malaria incidence are expen-
sive and logistically challenging in the context of routine
surveillance programmes, especially within Africa. The
SPR has been used as a practical and relatively inexpensive
alternative for tracking the burden of malaria over time.
Indeed, the use of the SPR is advocated by the World
Health Organization [1] and SPR measures have been
used as evidence of both temporal increases [12] and
decreases in the burden of malaria [7]. For example, rou-
tine surveillance data from four sites in The Gambia doc-
umented a decline in the SPR from 11-37% in 2003 to 2-
18% in 2007. This substantial reduction in SPR was tem-
porally linked to a more than three-fold increase in ITN
coverage and a change in anti-malarial treatment policy
[7]. Nevertheless, SPR remains a surrogate measure of the
burden of malaria and a better understanding of its rela-
tionship to malaria incidence is needed.
Based on the assumptions that there is no differential bias
in the subgroup of patients with suspected malaria who
undergo laboratory testing within a target population,
and that the incidence of non-malaria fevers does not
change over time, we show that there is a direct mathe-
matical relationship between the relative change in the
incidence of malaria (rΔIm) and the relative change in the
SPR. The rΔIm represents the ratio of incidence measures
over 2 consecutive time periods, where a value of 2 repre-
sents a 2-fold increase and a value of 0.5 represents a 2-
fold decrease in the incidence of malaria. It is important
to note that the relationship between SPR and the inci-
dence of malaria is neither linear nor proportional. For
example, a 5% absolute decline in SPR from 50% to 45%
corresponds to an 18% reduction in the incidence of
malaria (rΔIm = 0.82) while the same 5% absolute decline
in SPR from 10% to 5% corresponds to a 53% reduction
in the incidence of malaria (rΔIm = 0.47). Similarly, a
50% relative decline in SPR from 50% to 25% corre-
sponds to 67% reduction in the incidence of malaria
(rΔIm = 0.33) while the same 50% relative decline in SPR
from 10% to 5% corresponds to a 53% reduction in the
incidence of malaria (rΔIm = 0.47). Understanding the
mathematical relationship between changes in SPR and
changes in malaria incidence has important implications
for evaluating the impact of interventions using temporal
changes in SPR.
Date from the cohort used in this study offered a valuable
opportunity to test the relationship between changes in
SPR and changes in the incidence of malaria within a pop-
ulation of African children. Using the assumptions
described above, estimated values of rΔIm were calculated
for two, six, and 12 month intervals and compared them
to the corresponding observed values. While the SPR pro-
duced reasonable estimates of rΔIm over all three inter-
vals, there was some bias in the estimated values due to
the fact that the incidence of non-malaria fevers varied
over time. Indeed, the incidence of non-malaria fevers
showed marked seasonality as well as general decline over
the course of the study. These two variations had differing
effects, with seasonal changes in the incidence of non-
malaria fevers primarily affecting estimated changes in the
incidence of malaria over short time intervals (two
months), and an overall decline affecting longer time
intervals (12 months). The six month interval produced
the best predictions because it grouped the incidence of
non-malaria fevers into relatively equal seasons while
remaining short enough to minimize the effect of the gen-
eral decline in the incidence of non-malaria fevers over
time. Overall, these results show the significant and varied
effects that changing non-malaria fever rates can have on
the accuracy of SPR in predicting changes in the incidence
of malaria.
These results also demonstrate a consistent seasonal vari-
ation in the incidence of malaria and a decline in the inci-
dence of malaria as age increases, both of which are well
documented in other areas of Africa [13]. Substantial
changes in the incidence of malaria may be due to these
or other factors rather than the direct effect of malaria con-
trol interventions. As efforts to reduce the burden of
malaria intensify, it is prudent to consider secular trends
in malaria incidence when interpreting the effects of
malaria control interventions on any surveillance data,
including SPR.
Conclusion
The SPR has several advantages as a surrogate measure for
changes in the incidence of malaria using routine surveil-
lance data. Surveillance using SPR applies a consistent and
accepted case definition of malaria, is easy to integrate
into most health management information systems, and
can be done at a fraction of the cost of measuring the true
incidence of malaria. SPR can be a useful measure of the
impact of control interventions with several important
considerations. First, accurate measurement of SPR
requires the availability and utilization of quality labora-
tory diagnostic testing. Second, a change in SPR does not
correspond to a proportional or linear change in the inci-
dence of malaria. Third, when fever is used as the criterion
for laboratory testing, a change in the incidence of non-
malaria fevers can result in a change in SPR that does not
reflect the true change in the incidence of malaria. Forth,
additional factors such as age and seasonality can affect
the incidence of malaria and may exaggerate or conceal
the impact of interventions. Lastly, while SPR can be used
to estimate relative changes in the incidence of malaria
over time, it cannot estimate the actual incidence of
malaria in a target population. Additional studies are
needed to better understand the use of SPR in the context
of surveillance programmes. In this study, presumable allPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Malaria Journal 2009, 8:213 http://www.malariajournal.com/content/8/1/213
Page 8 of 8
(page number not for citation purposes)
febrile episodes were captured, laboratory testing was per-
formed on all patients who presented with a fever, and
laboratory testing for malaria was highly accurate. In con-
trast, most malaria surveillance systems only obtain a sub-
set of fevers in a target population and are often limited by
incomplete and inaccurate laboratory testing. The effect of
these factors on the ability of the SPR to accurately esti-
mate changes in the incidence of malaria may have impor-
tant implications for the interpretation of surveillance
using SPR in real world settings.
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